This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Ulaganathan Mabalirajan: Innovator in Asthma Treatment
Introduction
Ulaganathan Mabalirajan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of medical research, particularly in the treatment of bronchial asthma. His innovative work focuses on the development of compounds that inhibit specific pathways involved in asthma.
Latest Patents
Mabalirajan holds a patent for "Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma." This invention relates to compounds of general formula 1, which are designed to treat bronchial asthma by inhibiting the IL-4 or IL-5 pathways. The patent outlines methods for administering these compounds through various routes, including oral, intranasal, or inhalation, to effectively reduce perivascular and peribronchial inflammation.
Career Highlights
Ulaganathan Mabalirajan is associated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work has contributed to a better understanding of asthma and potential therapeutic approaches.
Collaborations
Mabalirajan has collaborated with esteemed colleagues such as Santu Bandyopadhyay and Balaram Ghosh. These partnerships have enhanced the scope and impact of his research in the field of respiratory health.
Conclusion
Ulaganathan Mabalirajan's innovative contributions to asthma treatment highlight the importance of research in developing effective therapies. His work continues to inspire advancements in medical science and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile